Diversify Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Diversify Advisory Services's BMY Position: Q2 2026 in Review
Diversify Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 463% in Q2 2026, buying an estimated $1.76M and bringing the position to 37,231 shares worth $2.33M. The position accounts for 0.04% of the portfolio, ranked #358.
Diversify Advisory Services first reported a position in BMY in Q1 2024 and has held it in 10 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Diversify Advisory Services held 37,231 shares of Bristol-Myers Squibb worth $2.33M as of Q2 2026.
- Diversify Advisory Services bought 30,623 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.76M.
- Bristol-Myers Squibb made up 0.04% of Diversify Advisory Services's portfolio in Q2 2026, its #358 holding.
- Diversify Advisory Services first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 10 quarters since.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.